Video Experimental Relacionado
Updated: Jan 23, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Hipertensión Arterial Pulmonar Asociada a Metanfetamina: Impacto, Mecanismos y un Marco para el Manejo
Namita Sood1, Jonika Weerasekare1, Iryna Zhyvylo1
1University of California Davis School of Medicine Davis California USA.
La hipertensión arterial pulmonar asociada a metanfetamina (HAP-Met) es una preocupación creciente. Esta revisión propone un enfoque de manejo pragmático, enfatizando la terapia oral temprana y la atención multidisciplinaria para mejores resultados.
Videos de Conceptos Relacionados
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Hypertension V: Nursing Management
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

